Trials / Sponsors / Lyell Immunopharma, Inc.
Lyell Immunopharma, Inc.
Industry · 7 registered clinical trials — 3 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Recruiting | A Study to Investigate Ronde-cel Versus Investigator's Choice CD19 CAR T-Cell Therapy Large B-cell Lymphoma, Lymphoma, B-Cell, Relapsed Non-Hodgkin Lymphoma | Phase 3 | 2026-01-12 |
| Withdrawn | A Study of IMPT-514 in Active Refractory Lupus Nephritis (LN) and Systemic Lupus Erythematosus (SLE) Systemic Lupus Erythematosus, Lupus Nephritis | Phase 1 / Phase 2 | 2024-02-15 |
| Terminated | A Biomarker Screening Protocol for Participants With Solid Tumors Triple Negative Breast Cancer, Non-small Cell Lung Cancer, Non Small Cell Lung Cancer | — | 2023-05-19 |
| Recruiting | Study of Rondecabtagene Autoleucel in Aggressive Large B-Cell Lymphoma Relapsed Non-Hodgkin Lymphoma, Refractory Non-Hodgkin Lymphoma, Non-Hodgkin Lymphoma | Phase 1 / Phase 2 | 2023-05-09 |
| Terminated | A Study to Investigate LYL845 in Adults With Solid Tumors Melanoma, Non-small Cell Lung Cancer, Colorectal Cancer | Phase 1 | 2022-12-19 |
| Recruiting | GCC19CART for Patients With Metastatic Colorectal Cancer Colorectal Cancer | Phase 1 | 2022-08-01 |
| Terminated | A Study to Investigate LYL797 in Adults With Solid Tumors Triple Negative Breast Cancer, TNBC - Triple-Negative Breast Cancer, Non-small Cell Lung Cancer | Phase 1 | 2022-03-29 |